ArticleMolecular cancer therapeutics2021

V-ATPase Inhibition Decreases Mutant Androgen Receptor Activity in Castrate-resistant Prostate Cancer.

Bradleigh Whitton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.